These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15238633)

  • 1. Solution NMR structure of the C-terminal domain of the human protein DEK.
    Devany M; Kotharu NP; Matsuo H
    Protein Sci; 2004 Aug; 13(8):2252-9. PubMed ID: 15238633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and isotopic labeling of structural domains of the human protein DEK.
    Devany M; Kotharu NP; Matsuo H
    Protein Expr Purif; 2005 Apr; 40(2):244-7. PubMed ID: 15766865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution NMR structure of the N-terminal domain of the human DEK protein.
    Devany M; Kappes F; Chen KM; Markovitz DM; Matsuo H
    Protein Sci; 2008 Feb; 17(2):205-15. PubMed ID: 18227428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR resonance assignments for the DNA-supercoiling domain of the human protein DEK.
    Devany M; Matsuo H
    J Biomol NMR; 2005 Jan; 31(1):65. PubMed ID: 15692740
    [No Abstract]   [Full Text] [Related]  

  • 5. The SAF-box domain of chromatin protein DEK.
    Böhm F; Kappes F; Scholten I; Richter N; Matsuo H; Knippers R; Waldmann T
    Nucleic Acids Res; 2005; 33(3):1101-10. PubMed ID: 15722484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional domains of the ubiquitous chromatin protein DEK.
    Kappes F; Scholten I; Richter N; Gruss C; Waldmann T
    Mol Cell Biol; 2004 Jul; 24(13):6000-10. PubMed ID: 15199153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.
    Fu GK; Grosveld G; Markovitz DM
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1811-5. PubMed ID: 9050861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DEK protein--an abundant and ubiquitous constituent of mammalian chromatin.
    Waldmann T; Scholten I; Kappes F; Hu HG; Knippers R
    Gene; 2004 Dec; 343(1):1-9. PubMed ID: 15563827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
    Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
    FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
    Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
    FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear DEK interactome supports multi-functionality.
    Smith EA; Krumpelbeck EF; Jegga AG; Prell M; Matrka MM; Kappes F; Greis KD; Ali AM; Meetei AR; Wells SI
    Proteins; 2018 Jan; 86(1):88-97. PubMed ID: 29082557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.
    Kappes F; Damoc C; Knippers R; Przybylski M; Pinna LA; Gruss C
    Mol Cell Biol; 2004 Jul; 24(13):6011-20. PubMed ID: 15199154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.
    Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F
    Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.
    McGarvey T; Rosonina E; McCracken S; Li Q; Arnaout R; Mientjes E; Nickerson JA; Awrey D; Greenblatt J; Grosveld G; Blencowe BJ
    J Cell Biol; 2000 Jul; 150(2):309-20. PubMed ID: 10908574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter.
    Sitwala KV; Adams K; Markovitz DM
    Oncogene; 2002 Dec; 21(57):8862-70. PubMed ID: 12483538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in studies on the DEK protein and its involvement in cellular apoptosis.
    Hua Y; Hu H; Peng X
    Sci China C Life Sci; 2009 Jul; 52(7):637-42. PubMed ID: 19641868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN.
    Fornerod M; Boer J; van Baal S; Morreau H; Grosveld G
    Oncogene; 1996 Oct; 13(8):1801-8. PubMed ID: 8895527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements.
    Fornerod M; Boer J; van Baal S; Jaeglé M; von Lindern M; Murti KG; Davis D; Bonten J; Buijs A; Grosveld G
    Oncogene; 1995 May; 10(9):1739-48. PubMed ID: 7753551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of the DEK protein in mammalian chromatin.
    Hu HG; Scholten I; Gruss C; Knippers R
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1008-14. PubMed ID: 17524367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of apoptosis related proteins regulated by proto-oncogene protein DEK.
    Kim DW; Chae JI; Kim JY; Pak JH; Koo DB; Bahk YY; Seo SB
    J Cell Biochem; 2009 Apr; 106(6):1048-59. PubMed ID: 19229864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.